Abbott ( Abbott )

Abbott

Abbott's picture

About Abbott

We are at work where people need us most. With sales, research, manufacturing and distribution facilities located throughout 150 countries, Abbott combines our diverse expertise with deep cultural insight to create products that meet local and regional health needs.

Abbott press release, blog etc

08/02/2018 - 12:58 Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
08/01/2018 - 14:48 Global Healthcare Organizations Join Abbott to Launch the UNIVANTS of Healthcare Excellence Award
07/27/2018 - 08:38 Abbott's FreeStyle Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S.
07/26/2018 - 08:31 Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
07/24/2018 - 17:33 Abbott Introduces Breakthrough Point-of-Care Test, the m-PIMA HIV-1/2 Viral Load (VL), at AIDS 2018 Amsterdam
07/11/2018 - 18:29 Abbott Receives FDA Approval for Next-Generation MitraClip Device to Treat People with Leaky Heart Valves
06/26/2018 - 02:31 Abbott Announces Freedom 2 Save Program for Employees to Address Student Debt
06/25/2018 - 03:22 New Late-Breaking Data at ADA Underscore Significant Benefits of Abbott's FreeStyle Libre System for People Living with Diabetes
06/21/2018 - 03:33 Abbott Receives FDA Clearance for Afinion HbA1c Dx for Diagnosing Diabetes
06/08/2018 - 03:53 Abbott Declares 378th Consecutive Quarterly Dividend
05/31/2018 - 08:33 Abbott Introduces the Afinion 2 Analyzer Rapid Test System for Diabetes Management
05/24/2018 - 05:52 Real-World Study Results Support Use of Abbott's AMPLATZER Amulet to Reduce Stroke in Patients Suffering from Atrial Fibrillation Without the Need for Lifetime Blood Thinners
05/23/2018 - 09:29 Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
05/23/2018 - 04:28 Abbott's Investigational Tendyne Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
05/22/2018 - 05:58 Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
05/22/2018 - 04:19 Treatment with Abbott's Portico Transcatheter Aortic Valve Showed Portico is Safe and Reduces Severe Aortic Stenosis at 30 Days in Real-World Setting
05/03/2018 - 06:57 Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
05/02/2018 - 09:36 Abbott's XIENCE Sierra Heart Stent Receives National Reimbursement in Japan to Treat People with Coronary Artery Disease